Sandoz reviews

4.0

79% would recommend to a friend

(875 total reviews)
avatar

Richard Saynor

86% approve of CEO

70% positive business outlook

Sandoz has an employee rating of 4.0 out of 5 stars, based on 875 company reviews on Glassdoor which indicates that most employees have a good working experience there. The Sandoz employee rating is in line with the average (within 1 standard deviation) for employers within the Farmacéutica y biotecnología industry (3.5 stars).

Reviews by job title

875 reviews
2.0
Feb 9, 2018
Recommend
CEO approval
Business Outlook

Pros

Good benefits and very reasonable work-life balance. Best in class office. Sandoz still is a US Gx market leader. Direct access to the wide US Gx market trends.

Cons

Lots of rumors about divestments. One of the three US production sites was already set for closure. US Gx business outlook does not promising. Significant number of Sandoz US senior managers are leaving the company, including the CEO.

2.0
Jan 20, 2018

Acct Manager

Recommend
CEO approval
Business Outlook

Pros

Growth of new and old products coming down the pike. Really good people here that want to do the right thing. Some leaders are awesome some not so much, but that any company. The awesome leaders though are starting to drink the koolaid.

Cons

Incentive structure for sales people is NOT pay for performance and salary not very competitive. Lack of "diversity" in management. They have taken away all incentives for employees to go above and beyond but you get paid for just doing your job (which is what people were going to do anyway) but you come to a company launching products in the hopes that not only are you doing the right thing for patients but as sales people the company will reward you. They have changed incentive program so many times and then penalize you if you don't hit one bucket. How can you even remember them all in addition to the fact that you will not get rewarded.

3.0
Sep 14, 2017
Recommend
CEO approval
Business Outlook

Pros

Overall, Sandoz provides competitive compensation packages, great benefits and some of the best facilities in the industry. They are one of the top generics firms in the world, and over the last 10 years, has invested heavily in specialty generics, specifically, biosimilars and respiratory drugs. They are also big players in the FTF (first to file) arena, aggressively targeting Paragraph IV filings and have had some huge successes over the last decade. Generics are here to stay, and Sandoz will probably be around for a long time providing innovative, generic alternatives for patients at prices far below the brand.

Cons

Sandoz, like many very large companies, is not as flexible and quick as a smaller firm would be. They tend to rely heavily on systems and controls, which, in itself, is a very good thing that will keep the company from committing critical mistakes. However, those same systems can inhibit reaction time to various issues, opportunities, and also reduces entrepreneurial spirit. Another negative is related to the investor-driven optics. Every quarter there are numbers to be met and investors (especially institutional) to keep happy. But negative events happen, and this is where the problems begin. A negative event is anything that will negatively impact net sales and profit, like sales of a blockbuster drug falling off much more quickly than expected. This leads to cost cutting exercises to try (and usually fail) to meet the bottom line profit number. Trying to hit the number is a good thing. But sacrificing the future to varying degrees (through layoffs, consolidations, downsizing, etc.) is not. This has impacts to both the health of the company, as well as the perception from the outside world.

Viewing 37 - 39 of 875 Reviews

Glassdoor has 1,546 Sandoz reviews submitted anonymously by Sandoz employees. Read employee reviews and ratings on Glassdoor to decide if Sandoz is right for you.